BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260317T000000
DTEND;TZID=America/Los_Angeles:20260319T235959
DTSTAMP:20260414T213409
CREATED:20251107T152844Z
LAST-MODIFIED:20251107T152844Z
UID:9472-1773705600-1773964799@thebiocalendar.com
SUMMARY:Rare Disease Summit
DESCRIPTION:The Rare Disease Summit\, March 17-19\, 2026 in Philadelphia\, PA\, unites stakeholders to accelerate therapeutic innovation for areas of unmet medical need. Gain actionable insights on launch planning\, market access\, reimbursement strategies and strategic partnerships to optimize rare disease commercialization and elevate patient impact. Learn more at www.informaconnect.com/rare. Save 10% with code 26B4B10.*
URL:https://thebiocalendar.com/event/rare-disease-summit-2/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2025/11/RareDisease_EmailHeaders20.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260317T080000
DTEND;TZID=America/New_York:20260319T170000
DTSTAMP:20260414T213409
CREATED:20251107T153148Z
LAST-MODIFIED:20251107T153148Z
UID:9476-1773734400-1773939600@thebiocalendar.com
SUMMARY:PAP – Patient Assistance & Access Programs
DESCRIPTION:Stakeholders unite at the ultimate forum – PAP – Patient Assistance & Access Programs convenes influential stakeholders and top leaders from across the assistance\, access and affordability arena to talk strategies for program optimization and provide crucial updates on evolving health policy and shifting market dynamics to transform patient outcomes\, maximize medication access and prioritize the patient experience. Prepare for crucial discussions to maximize patient access and robust networking opportunities to expand your network and establish powerful partnerships.
URL:https://thebiocalendar.com/event/pap-patient-assistance-access-programs-3/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2025/11/PAP26_600x200.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260317T080000
DTEND;TZID=America/Los_Angeles:20260319T170000
DTSTAMP:20260414T213409
CREATED:20251107T153243Z
LAST-MODIFIED:20251107T153243Z
UID:9480-1773734400-1773939600@thebiocalendar.com
SUMMARY:Hub and Specialty Pharmacy Models East
DESCRIPTION:Unlock your hub’s fullest potential at Hub and Specialty Pharmacy Models East. Key stakeholders unite to collaborate and discuss evolving regulations\, shifting market dynamics and innovative solutions to accelerate access and drive an all-encompassing\, state-of-the-art hub. Prepare for contemporary solutions to optimize your hub model and robust networking opportunities to expand your network and establish powerful partnerships.
URL:https://thebiocalendar.com/event/hub-and-specialty-pharmacy-models-east-4/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2025/11/HubE26_600x200.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260317T100000
DTEND;TZID=America/Los_Angeles:20260317T110000
DTSTAMP:20260414T213409
CREATED:20260219T155126Z
LAST-MODIFIED:20260219T155126Z
UID:9928-1773741600-1773745200@thebiocalendar.com
SUMMARY:Demystifying AI in Modern MedTech
DESCRIPTION:In this practical\, example driven webinar\, Battelle Technical Fellow\, Justin Sanchez\, together with leading MedTech experts\, will break down how AI can be applied to accelerate device development while ensuring safety\, reliability\, and regulatory alignment. \nIn this free session\, you will learn:\n– How AI delivers value across medical device development\n– Practical\, real-world examples you can apply\n– A clear\, accessible introduction to AI’s role in modern MedTech
URL:https://thebiocalendar.com/event/demystifying-ai-in-modern-medtech/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/03-17-26-Battelle-eblast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260317T110000
DTEND;TZID=America/Los_Angeles:20260317T120000
DTSTAMP:20260414T213409
CREATED:20260219T154840Z
LAST-MODIFIED:20260219T154840Z
UID:9924-1773745200-1773748800@thebiocalendar.com
SUMMARY:Clinical Supply Chain Therapy: Lowering Risk (And Your Blood Pressure)
DESCRIPTION:Join Deputy Chief Editor of Outsourced Pharma Jeff Buguliskis and our experienced panelists as they break down how to transform your CDMO partnerships from sources of stress into strategic assets.  \nWe will share real-world tactics to help you secure your outsourcing strategy\, navigate regional regulatory hurdles\, and prevent costly delays.
URL:https://thebiocalendar.com/event/clinical-supply-chain-therapy-lowering-risk-and-your-blood-pressure/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/Biocal-9.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260317T160000
DTEND;TZID=America/Los_Angeles:20260317T183000
DTSTAMP:20260414T213409
CREATED:20260217T154830Z
LAST-MODIFIED:20260217T154830Z
UID:9907-1773763200-1773772200@thebiocalendar.com
SUMMARY:BVS' Biotech Community Event at SOVA Science District\, San Diego
DESCRIPTION:We are very excited to announce our outdoor Biotech Community Event at SOVA Science District. \nThis is a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \nOur last events were a HUGE success with 300 high-quality people registering from over 100+ companies/institutes & we will once again be inviting the entire So CA Life Science Community to attend. \n✨ What to Expect: \n    Vendor Exhibits: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\n    Networking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\n    Delicious Tacos & Beer: Enjoy delicious Tacos as you network and explore the vendor exhibits. \nAdmission Details:\nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions\,etc.) from life science companies and research institutes.\n$200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-biotech-community-event-at-sova-science-district-san-diego-9/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/02/BVS-Biotech-Event-Flyer-03-17-26.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260318T110000
DTEND;TZID=America/Los_Angeles:20260318T120000
DTSTAMP:20260414T213409
CREATED:20260219T155520Z
LAST-MODIFIED:20260219T155520Z
UID:9932-1773831600-1773835200@thebiocalendar.com
SUMMARY:Enhanced Biotherapeutic Protein Expression Using Advanced Vector Systems
DESCRIPTION:Struggling to improve titre\, product quality\, or long-term stability in GS-CHO expression systems? \nIn this free webinar\, learn how optimized vector design — including advanced promoter engineering — can significantly impact biomanufacturing performance. The session highlights the Lonza GSquad® Pro platform and its high-performance LHP-1 promoter\, along with data-driven strategies to improve gene expression control in CHO cells. \nYou’ll gain insights into:\n– Critical CHO vector design elements\n– Performance advantages of next-generation vector platforms\n– Emerging approaches to strengthening expression stability and output
URL:https://thebiocalendar.com/event/enhanced-biotherapeutic-protein-expression-using-advanced-vector-systems/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/03-18-26-Lonza-eblast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260318T110000
DTEND;TZID=America/Los_Angeles:20260318T120000
DTSTAMP:20260414T213409
CREATED:20260225T145818Z
LAST-MODIFIED:20260225T145818Z
UID:9972-1773831600-1773835200@thebiocalendar.com
SUMMARY:Large Molecule Biologics Delivery: Aligning Formulations\, Doses\, And Devices
DESCRIPTION:Selecting the right route of administration for a complex\, large molecule biologic requires careful alignment of formulation\, dose\, and device strategy. Join Drug Delivery Leader’s next live discussion where experts from Merck\, GSK\, and Drug Hunter Consulting will share key considerations—including formulation complexity\, high-dose delivery\, patient needs\, self-administration\, and transitioning between delivery platforms—using examples from prefilled syringes\, autoinjectors\, and combination products.
URL:https://thebiocalendar.com/event/large-molecule-biologics-delivery-aligning-formulations-doses-and-devices/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/Biocal-10.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260319T100000
DTEND;TZID=America/Los_Angeles:20260319T110000
DTSTAMP:20260414T213409
CREATED:20260212T173419Z
LAST-MODIFIED:20260212T173419Z
UID:9899-1773914400-1773918000@thebiocalendar.com
SUMMARY:Ensuring Consistent Quality in Pharmaceutical Water for Injection (WFI) Systems
DESCRIPTION:Water plays a vital role across pharmaceutical manufacturing. It is used as a component of fermentation media\, a solvent in production\, and a cornerstone of cleaning and rinsing procedures.  \nTo safeguard product integrity and protect patients\, disciplined preventive maintenance\, practical risk assessment\, and routine monitoring are essential across the system at every critical point of use. Together\, these measures create a resilient\, well-characterized water system that enables manufacturers to operate with confidence and maintain sustained control over their environments. \nKey Learning Objectives: \n    Understand how water quality can directly impact product safety and compliance\n    Identify practical strategies to reduce contamination\n    Build confidence in maintaining a resilient\, compliant water system
URL:https://thebiocalendar.com/event/ensuring-consistent-quality-in-pharmaceutical-water-for-injection-wfi-systems/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/03-19-26-Particle-Measuring-Systems-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260319T110000
DTEND;TZID=America/Los_Angeles:20260319T120000
DTSTAMP:20260414T213409
CREATED:20260210T210536Z
LAST-MODIFIED:20260210T210536Z
UID:9859-1773918000-1773921600@thebiocalendar.com
SUMMARY:Solving Particulates and Material Variability in CGT Manufacturing
DESCRIPTION:Particulates and raw material variability remain two of the toughest\, most talked about hurdles in cell and gene therapy.  \nIn the upcoming Cell & Gene Live\, Anthony Blaszczyk\, Ph.D.\, Senior Scientist at the U.S. Pharmacopeia\, and Basak Clements\, Ph.D.\, Founder and Senior Advisor at biomatria\, join Cell & Gene Chief Editor Erin Harris to examine industry efforts to establish meaningful standards for particulate control (both visible and subvisible) across CGT products. \nThe discussion will address the limitations of current testing methods and the need for a holistic\, risk-based approach that manages particulates from raw materials through final product. We will also explore how variability drives batch failures and CMC delays\, and how emerging digital QC systems and earlier supplier partnerships are helping organizations reduce these risks.
URL:https://thebiocalendar.com/event/solving-particulates-and-material-variability-in-cgt-manufacturing/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/26_03-CGL-Socials-1000x1250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260319T110000
DTEND;TZID=America/New_York:20260319T133000
DTSTAMP:20260414T213409
CREATED:20260223T181004Z
LAST-MODIFIED:20260223T181004Z
UID:9957-1773918000-1773927000@thebiocalendar.com
SUMMARY:BVS' Waltham/Winter Street Biotech Community Expo\, Waltham
DESCRIPTION:We are very excited to invite you to our indoor BVS Waltham/Winter Street Biotech Community Expo! \nMark your calendars for a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \nWe are inviting all research scientists from the institutes\, biotech/pharma and other companies along Winter Street and surrounding areas to attend this event. \n✨ What to Expect:\n    Vendor Exhibits: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\n    Networking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\n    Delicious Food & Drinks: Enjoy delicious food & refreshments as you network and explore the vendor exhibits. \nAdmission Details:\nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions etc.) from life science companies and research institutes.\n$200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-waltham-winter-street-biotech-community-expo-waltham-4/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/02/BVS-Biotech-Event-Flyer-03-19-26.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260319T130000
DTEND;TZID=America/Los_Angeles:20260319T140000
DTSTAMP:20260414T213409
CREATED:20260219T155819Z
LAST-MODIFIED:20260219T155819Z
UID:9936-1773925200-1773928800@thebiocalendar.com
SUMMARY:Accelerating Vector Construction-to-IND: Achieving a 9-Month Timeline Through Integrated Cell Line Development
DESCRIPTION:Join this free webinar to see how Samsung Biologics integrates in-house vector construction and Master Cell Bank (MCB) manufacturing to streamline the VC-to-IND journey to approximately 9 months. \nYou’ll learn how tighter alignment between vector design and cell banking:\n– Reduces handoffs and accelerates decision-making\n– Improves data continuity and risk management\n– Enhances predictability in early-stage development
URL:https://thebiocalendar.com/event/accelerating-vector-construction-to-ind-achieving-a-9-month-timeline-through-integrated-cell-line-development/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/03-19-26-Samsung-eblast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260323
DTEND;VALUE=DATE:20260327
DTSTAMP:20260414T213409
CREATED:20260218T112126Z
LAST-MODIFIED:20260218T112126Z
UID:9911-1774224000-1774569599@thebiocalendar.com
SUMMARY:DCAT Week
DESCRIPTION:DCAT Week is the premier global event convening annually in New York City for companies engaged in the Bio/Pharmaceutical business ecosystem. It is hosted by the Drug\, Chemical & Associated Technologies Association (DCAT)\, a not-for-profit\, corporate member-supported\, global business development association whose unique membership model integrates both innovator and generic drug manufacturers with suppliers of ingredients\, development and manufacturing services\, and related technologies.
URL:https://thebiocalendar.com/event/dcat-week/
LOCATION:New York\, New York\, NY\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260323
DTEND;VALUE=DATE:20260326
DTSTAMP:20260414T213409
CREATED:20251105T134054Z
LAST-MODIFIED:20251105T134115Z
UID:9439-1774224000-1774483199@thebiocalendar.com
SUMMARY:BIO-Europe Spring
DESCRIPTION:BIO-Europe Spring is a leading springtime partnering conference for the biopharma and life sciences industries that connects companies\, academics\, and investors to foster strategic partnerships. It offers a hybrid experience with both in-person and online components\, featuring one-on-one meetings facilitated by the partneringONE® platform\, along with workshops\, company presentations\, and an exhibition. The event aims to cultivate new collaborations and partnerships by bringing together executives from around the world to network and discuss the latest industry challenges and innovations.
URL:https://thebiocalendar.com/event/bio-europe-spring-2/
LOCATION:Lisbon\, Lisbon\, Portugal
CATEGORIES:Expo,Featured,Forum,Partnering
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/11/bes.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260323T080000
DTEND;TZID=America/Los_Angeles:20260323T153000
DTSTAMP:20260414T213409
CREATED:20260112T174740Z
LAST-MODIFIED:20260112T174911Z
UID:9776-1774252800-1774279800@thebiocalendar.com
SUMMARY:New Jersey Inaugural Symposium for Life Science Innovation and Development
DESCRIPTION:THEME | Beyond the Medicine Chest of the World: Looking Towards the Future of Health and Medicine \nA Special Full-Day Conference for Senior Executives and Key Thought Leaders in the Life Sciences Industry \nMonday\, March 23\n8:00am — 2:30pm\nReception to Follow \nThe Rutgers Club\n85 Avenue E\, 2nd Fl.\nPiscataway\, NJ 08854
URL:https://thebiocalendar.com/event/new-jersey-inaugural-symposium-for-life-science-innovation-and-development/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/Jersey-Banner-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260323T100000
DTEND;TZID=America/New_York:20260325T163000
DTSTAMP:20260414T213409
CREATED:20260107T102424Z
LAST-MODIFIED:20260107T102738Z
UID:9720-1774260000-1774456200@thebiocalendar.com
SUMMARY:Life Sciences Accounting & Reporting Congress 2026
DESCRIPTION:The premier event for life sciences CFOs\, controllers and accounting leaders returns for its 21st year as the essential forum for navigating today’s most pressing financial challenges. As regulations evolve at unprecedented speed and new technologies transform financial operations\, this is where 350+ industry leaders converge to share proven strategies\, explore emerging solutions\, and build the connections needed to stay ahead. Through specialized sessions for companies of all sizes – from emerging biotechs to global enterprises – you’ll gain actionable insights to tackle regulatory shifts\, optimize accounting practices\, and evaluate financial technologies that are reshaping the sector – all while building valuable relationships with peers who understand your unique challenges. (CPE accredited)
URL:https://thebiocalendar.com/event/life-sciences-accounting-reporting-congress-2026/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/LS_Accounting_Reporting-MediaPartner_Big4Bio-Listing-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260324
DTEND;VALUE=DATE:20260327
DTSTAMP:20260414T213409
CREATED:20251212T172657Z
LAST-MODIFIED:20251212T172744Z
UID:9646-1774310400-1774569599@thebiocalendar.com
SUMMARY:Patients as Partners in Clinical Research
DESCRIPTION:13th Annual:\nDemonstrating HOW Patient Involvement\n​​​​​​​Gets Done to Enhance Access and Accelerate Medicine Development\n  \n\n\n\n\nPatients as Partners® in Clinical Research is the first conference dedicated to raising the patient voice in R&D to drive better clinical outcomes for all. Guided by a steering committee of Pharma R&D leaders\, the FDA\, patient advocates\, and engagement professionals\, the program is thoughtfully curated to deliver the latest insights\, strategies and case studies for implementing patient-centric approaches in drug development. \nThe event provides actual examples of progress and measurable value\, demonstrating how patient insights can drive efficiencies and improve outcomes. \nWe are thrilled to announce that the Patients as Partners in Clinical Research conference is now part of Fierce Life Sciences. Combining our resources allows for greater market reach\, more networking and partnering.
URL:https://thebiocalendar.com/event/patients-as-partners-in-clinical-research-4/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Forum,Networking
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260324T110000
DTEND;TZID=America/Los_Angeles:20260324T120000
DTSTAMP:20260414T213409
CREATED:20260223T130511Z
LAST-MODIFIED:20260223T130511Z
UID:9951-1774350000-1774353600@thebiocalendar.com
SUMMARY:Process Control's Increasing Role in Biosimilar Approval
DESCRIPTION:Regulators are moving the comparability goalpost\, shifting the burden of proof from massive clinical trials to deep process understanding. In this new landscape\, the ability to define and control CPPs is the only way to ensure a biosimilar remains highly similar to its reference. \nJoin Bioprocess Online’s Jon O’Connell for a virtual Q&A with experts exploring how QbD principles and an understanding of reference product CQAs should guide biosimilar process development to smooth the path to regulatory approval.  \nThis Bioprocess Online Live event will feature industry veterans\, biosimilars experts and principal consultants who will offer guidance and insight you won’t want to miss.
URL:https://thebiocalendar.com/event/process-controls-increasing-role-in-biosimilar-approval/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/1771601868346.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260324T110000
DTEND;TZID=America/Los_Angeles:20260324T120000
DTSTAMP:20260414T213409
CREATED:20260225T150248Z
LAST-MODIFIED:20260225T150248Z
UID:9976-1774350000-1774353600@thebiocalendar.com
SUMMARY:Flexible Therapeutic Development: Balancing Speed\, Cost\, and Process
DESCRIPTION:Explore how KBI Biopharma delivers fast\, cost-effective\, and robust microbial protein process development\, tailored for first-in-human (FIH\, Phase I) programs and adaptable to each client’s needs for speed\, cost\, and performance. \nLearning Objectives:\n– Key considerations for microbial cell line\, fermentation\, and purification development for FIH\n– How milestones align from proof-of-concept to toxicology material\n– How platform-based and robotic workflows can optimize cost\, speed\, or robustness—no license fee required
URL:https://thebiocalendar.com/event/flexible-therapeutic-development-balancing-speed-cost-and-process/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/03-24-26-KBI-eblast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260324T130000
DTEND;TZID=America/Los_Angeles:20260324T140000
DTSTAMP:20260414T213409
CREATED:20260218T144306Z
LAST-MODIFIED:20260218T144306Z
UID:9912-1774357200-1774360800@thebiocalendar.com
SUMMARY:From Breakdown to Breakthrough: The Maturity Journey for Asset Performance Management (APM)
DESCRIPTION:Asset Performance Management (APM) has evolved far beyond reactive maintenance – but many organizations are still navigating how to get there.  In this session\, Chief Platform Architect at Blue Mountain\, Bill Lucas\, walks through the industry’s APM maturity journey\, tracing the shift from breakdown-driven maintenance to predictive and AI-powered optimization.
URL:https://thebiocalendar.com/event/from-breakdown-to-breakthrough-the-maturity-journey-for-asset-performance-management-apm/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/03-24-26-Blue-Mountain-Reg-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260325
DTEND;VALUE=DATE:20260328
DTSTAMP:20260414T213409
CREATED:20260212T143153Z
LAST-MODIFIED:20260212T143234Z
UID:9898-1774396800-1774655999@thebiocalendar.com
SUMMARY:LSX World Congress Europe
DESCRIPTION:LSX World Europe (LSX Europe) is a leading life science fundraising and investment event\, bringing innovators and investors together through strategic 1:1 meetings and targeted networking. \nEarly-stage (Seed–Series B) biotech\, medical device\, diagnostics and digital health companies\, including university spin-outs – join to secure investment and build collaborations. \nActive life science investors attend\, looking for new investments and syndication. \nThrough our proven partnering format\, conversations turn into real partnerships and successful raises.
URL:https://thebiocalendar.com/event/lsx-world-congress-europe/
LOCATION:Lisbon\, Lisbon\, Portugal
CATEGORIES:Partnering
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260326T060000
DTEND;TZID=America/Los_Angeles:20260326T070000
DTSTAMP:20260414T213409
CREATED:20260310T161448Z
LAST-MODIFIED:20260310T161448Z
UID:9996-1774504800-1774508400@thebiocalendar.com
SUMMARY:2026 Manufacturing Trends Reshaping Life Sciences: AI\, Integration\, and Workforce Readiness
DESCRIPTION:Learn how leading manufacturers are connecting manufacturing\, quality\, and supply chain systems to improve visibility\, accelerate decision making and create more agile operations. The session will explore how organizations are strengthening supply chains and preparing their workforce for increasingly digital manufacturing environments.
URL:https://thebiocalendar.com/event/2026-manufacturing-trends-reshaping-life-sciences-ai-integration-and-workforce-readiness/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/03-26-26-MasterControl-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260326T080000
DTEND;TZID=America/Los_Angeles:20260326T170000
DTSTAMP:20260414T213409
CREATED:20260212T142522Z
LAST-MODIFIED:20260218T164505Z
UID:9896-1774512000-1774544400@thebiocalendar.com
SUMMARY:Charles River Cell & Gene Therapy Summit
DESCRIPTION:Returning to Boston this March \n\n\n\n\n\n\n\n\n\n\n\n\nConnect with Fellow Leaders Shaping Cell and Gene Therapy Development\n\n\n\n\n\n\n\n\n\n\n\n\n  \nThe eighth in a series of premier one-day events held in the world’s biggest biotech hubs\, Charles River is bringing together the leading experts\, executives\, and thought leaders in the CGT space to discuss and navigate critical challenges. \nRegister today to save your seat for an exclusive event aimed to inspire\, educate\, and connect you with the people shaping the future of advanced therapies.
URL:https://thebiocalendar.com/event/charles-river-cell-gene-therapy-summit/
LOCATION:Cambridge\, MA\, Cambridge\, MA\, 02139\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260326T130000
DTEND;TZID=America/Los_Angeles:20260326T140000
DTSTAMP:20260414T213409
CREATED:20260220T124433Z
LAST-MODIFIED:20260220T124433Z
UID:9943-1774530000-1774533600@thebiocalendar.com
SUMMARY:Avoiding Scale-Up Surprises: Applying AI and Rapid Prototyping to Media and Process Development
DESCRIPTION:As biologics grow more complex and development timelines continue to tighten\, many teams could encounter manufacturability challenges related to decisions around media\, process\, and scalability made earlier in development. Traditional\, sequential workflows may not always surface potential challenges until programs are already moving toward scale-up\, which can limit flexibility. \nIn this webinar\, Thermo Fisher Scientific experts discuss factors that contribute to manufacturability challenges during the transition from development to manufacturing. The session walks through a representative development journey\, including early insights from AI\, data modeling\, and analytical testing\, followed by media and process development\, qualification through rapid prototyping\, and considerations for large-scale cGMP manufacturing. \nDuring this session\, attendees will hear perspectives on how teams may:\n~ Consider manufacturability earlier in biologics development\n~ Inform development decisions with AI and data modeling\n~ Apply rapid prototyping to evaluate media and process choices\n~ Support development decisions prior to cGMP scale-up
URL:https://thebiocalendar.com/event/avoiding-scale-up-surprises-applying-ai-and-rapid-prototyping-to-media-and-process-development/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/03-26-26-Thermo-Reg-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260326T130000
DTEND;TZID=America/Los_Angeles:20260326T140000
DTSTAMP:20260414T213409
CREATED:20260224T125549Z
LAST-MODIFIED:20260224T125716Z
UID:9961-1774530000-1774533600@thebiocalendar.com
SUMMARY:Why Open-Source Models Matter for Computational Drug Discovery
DESCRIPTION:AI is reshaping every industry—and drug discovery is no exception. Across targets\, molecules\, and data at massive scale\, AI is becoming integral to how modern therapeutics are discovered and developed. \nThis panel explores how foundational open‑source AI engines like OpenFold and Boltz are being used across the drug discovery workflow\, from target discovery and validation to hit identification and lead optimization. Panelists will discuss the growing role of structural modeling\, chemoinformatics\, and predictive machine learning\, including how open models can enable faster structure–activity insights\, earlier toxicity prediction\, and more efficient decision‑making. The conversation will also touch on antibiotic discovery\, where AI is helping researchers break through long‑standing scientific and economic barriers by identifying new mechanisms\, molecular scaffolds\, and design strategies. \nThis session is designed for scientists and leaders seeking to understand where open-source AI is delivering real impact today—and why AI is no longer optional for staying competitive in drug discovery.
URL:https://thebiocalendar.com/event/why-open-source-models-matter-for-computational-drug-discovery/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/26_03-DDO-NL-468x60-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260331T110000
DTEND;TZID=America/Los_Angeles:20260331T120000
DTSTAMP:20260414T213409
CREATED:20260220T125345Z
LAST-MODIFIED:20260220T125345Z
UID:9947-1774954800-1774958400@thebiocalendar.com
SUMMARY:Digital Design Meets Proven Performance: The Future of Single-Use Assemblies
DESCRIPTION:In today’s fast-paced biopharma and CDMO environments\, single-use assembly design is about confidence in quality\, supply continuity\, and process performance. This webinar explores how Thermo Scientific™ Single-Use Assemblies are designed to help reduce risk\, support flexible manufacturing\, and help organizations meet production milestones and maintain momentum when time to market is crucial. \nAttendees will see how automation-driven tools – including the Kaon™ app and the online Single-Use Assembly Configurator\, simplify and standardize assembly design. By bringing a broad\, trusted portfolio of components into one intuitive digital experience\, these tools accelerate design decisions\, improve consistency\, and reduce the effort required to move from concept to execution. \nWe will highlight three core considerations that set Thermo Scientific Single-Use Assemblies apart and deliver tangible value in real-world bioprocessing operations: \n    ~ Film technology for durable\, consistent performance across 2D and 3D bioprocess containers\n    ~ Integration of LifeASSURE™ sterilizing grade filters that streamline qualification\n    ~ Protection of process integrity at critical connection points to reduce risks of leaks \nJoin this webinar to learn how a standardized\, automated configuration experience\, backed by proven Thermo Scientific technologies to help biopharma and CDMO teams move faster\, reduce risk\, and execute with confidence.
URL:https://thebiocalendar.com/event/digital-design-meets-proven-performance-the-future-of-single-use-assemblies/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/03-31-26-Thermo-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260331T110000
DTEND;TZID=America/Los_Angeles:20260331T120000
DTSTAMP:20260414T213409
CREATED:20260303T140956Z
LAST-MODIFIED:20260303T140956Z
UID:9983-1774954800-1774958400@thebiocalendar.com
SUMMARY:The Phase 2 Endpoint Dilemma: Bridging Subjective Scales and Objective Measures in Neurodegenerative Trials
DESCRIPTION:Phase 2 neurodegenerative trials are increasingly challenged by slow disease trajectories\, heterogeneous patient populations\, and blunt legacy endpoints that struggle to detect treatment-related change over typical study durations. Traditional scales such as ADAS-Cog and MDS-UPDRS\, while well-established\, often lack sensitivity in early disease\, are vulnerable to rater and practice effects\, and may insufficiently capture subtle but clinically meaningful benefits. \nThis webinar will examine when and how to move beyond single-scale approaches toward more informative composite strategies\, highlighting circumstances in which composites enhance signal detection versus when they introduce additional noise\, complexity\, and interpretability risk. We will explore practical frameworks for integrating functional\, cognitive\, and biomarker measures into coherent endpoint hierarchies that support both mechanistic insight and regulatory relevance. Finally\, we will discuss how real-world evidence and natural history data can be leveraged to select\, calibrate\, and power Phase 2 endpoints capable of detecting meaningful change within shorter trial timeframes\, improving go/no-go decision quality for emerging neurodegenerative therapies. \nKey Learning Objectives:\n– Evaluate the strengths and limitations of traditional subjective scales (e.g.\, ADAS-Cog\, MDS-UPDRS) in Phase 2 neurodegenerative trials and identify when alternative or composite strategies are warranted \n– Apply practical frameworks to integrate cognitive\, functional\, and biomarker endpoints into coherent\, regulator-ready hierarchies that enhance signal detection while minimizing interpretability risk \n– Leverage real-world evidence and natural history datasets to inform endpoint selection\, calibration\, and powering strategies that improve Phase 2 go/no-go decision-making
URL:https://thebiocalendar.com/event/the-phase-2-endpoint-dilemma-bridging-subjective-scales-and-objective-measures-in-neurodegenerative-trials/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/Untitled-design-59.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260407T100000
DTEND;TZID=America/Los_Angeles:20260409T120000
DTSTAMP:20260414T213409
CREATED:20260224T154635Z
LAST-MODIFIED:20260224T154635Z
UID:9968-1775556000-1775736000@thebiocalendar.com
SUMMARY:Cell & Gene Tech Expo
DESCRIPTION:The Cell & Gene Tech Expo is designed to aid professionals in discovering the latest advancements and equipment critical to cell and gene therapy development. Attendees will explore state-of-the-art solutions such as bioreactor systems\, cell sorting and isolation technologies\, automated platforms\, non-viral gene editing tools like electroporation and CRISPR\, data monitoring tools\, sterilization solutions\, and more. \nThis digital event is free for Cell & Gene subscribers and offers an alternative to in-person events which can be costly\, ineffective\, and time-consuming. Through this virtual platform\, professionals can effortlessly connect with various suppliers\, making the selection process more accessible and informed. \nCell Therapy Solutions – April 7\, 2026\nGene Therapy Solutions – April 8\, 2026\nCommercial Readiness – April 9\, 2026
URL:https://thebiocalendar.com/event/cell-gene-tech-expo/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/02/cellgeneexpo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260407T163000
DTEND;TZID=America/New_York:20260407T200000
DTSTAMP:20260414T213409
CREATED:20260325T192643Z
LAST-MODIFIED:20260327T171116Z
UID:10069-1775579400-1775592000@thebiocalendar.com
SUMMARY:Builds Bio+ NY Metro Life Science Outlook & Networking Reception
DESCRIPTION:The life sciences and biotech community navigated a historically challenging landscape in 2025. Between shifts in federal agency structures and financial hurdles on Wall Street\, the industry faced significant uncertainty. \nHowever\, innovation has not slowed down. From CRISPR gene-editing breakthroughs to AI-bolstered drug discovery and advances in materials science\, the potential for progress remains stronger than ever. \nJoin Builds Bio+ at Arnold & Porter as we analyze the initiatives driving the region forward. We will discuss the findings of Governor Hochul’s Emerging Technology Advisory Board and explore how 2026 is positioned to propel the NY Metro area to the forefront of global biotechnology. \nLocation: Arnold & Porter\,\n250 West 55th Street\,\nNew York\, NY 10019-9710
URL:https://thebiocalendar.com/event/ny-metro-life-science-outlook-networking-reception/
LOCATION:Arnold & Porter\, 250 West 55th Street\, New York\, 10019\, United States
CATEGORIES:Networking
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/480-x-270-px-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260409
DTEND;VALUE=DATE:20260410
DTSTAMP:20260414T213409
CREATED:20260214T231312Z
LAST-MODIFIED:20260214T231312Z
UID:9906-1775692800-1775779199@thebiocalendar.com
SUMMARY:Life Sciences Future SW
DESCRIPTION:The Life Sciences Future SW conference will unite stakeholders from the region and beyond\, including life sciences start-ups\, established industry leaders\, academic institutions\, healthcare providers\, and investors. \nThis event will strengthen connections with the Southwest region while fostering new relationships across the state. The conference aims to create a more cohesive and thriving regional ecosystem that supports business growth\, innovation\, and collaboration in the life sciences sector.
URL:https://thebiocalendar.com/event/life-sciences-future-sw-2/
LOCATION:Pittsburgh\, Pittsburgh\, PA\, United States
CATEGORIES:Summit
END:VEVENT
END:VCALENDAR